RACK1通过抑制RPS2的全方位化,促进NF-κB通路的激活和质瘤细胞的增殖
Peng Cao1, Jun Tan1, Pinjing Zhang1
1Department of Neurosurgery, General Hospital of Northern Theater Command, No.83 Wenhua Road,, Shenyang, Liaoning, 110840, China.
Molecular biology reports
|June 16, 2025
概括
活性C激酶1受体 (RACK1) 通过稳定Ribosomal Protein S2 (RPS2),激活NF-κB通路来促进质瘤的生长. 这种相互作用凸显了RACK1和RPS2作为侵略性脑瘤的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质瘤是一种具有不良预后的侵袭性脑瘤.
- 激活C激酶1 (RACK1) 和核糖体蛋白S2 (RPS2) 的受体与瘤进展有关.
- 在质母细胞瘤中RACK1和RPS2的联合作用尚不清楚.
研究的目的:
- 调查RACK1和RPS2在质母细胞瘤中的联合作用.
- 阐明RACK1和RPS2影响质瘤进展的分子机制.
- 为了确定质瘤的潜在治疗点.
主要方法:
- 对质瘤数据集 (GSE41031,TCGA-质瘤) 的生物信息分析,以确定差异表达基因 (DEG) 并执行蛋白质-蛋白质相互作用 (PPI) 网络分析.
- 在体外分析RACK1和RPS2表达和功能在质瘤细胞系.
- 共同免疫沉 (Co-IP),无处不在的测试,西部抹杀和露西法酶记者测试,以调查蛋白质相互作用,稳定性和路径激活 (NF-κB).
主要成果:
- RACK1和RPS2被确定为在质瘤中显著上调的枢纽基因,并与增加的细胞增殖,迁移和入侵有关.
- 通过降低林B1和CDK1.1的调节,通过RACK1敲击诱导的G2/M阶段细胞周期停止.
- RACK1通过抑制其因乌比奎丁介导的降解来稳定RPS2,从而促进NF-κB通路和质瘤细胞生长. 沉默RPS2也抑制了扩散.
结论:
- RACK1通过通过抑制RPS2无处不在和降解来增强NF-κB通路激活来促进质瘤细胞的扩散和入侵.
- RACK1和RPS2代表了潜在的生物标志物和治疗质瘤进展的点.
相关概念视频
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K


